0001447362-21-000040.txt : 20210310 0001447362-21-000040.hdr.sgml : 20210310 20210310160818 ACCESSION NUMBER: 0001447362-21-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210308 FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRADBURY DANIEL CENTRAL INDEX KEY: 0001236397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38984 FILM NUMBER: 21729756 MAIL ADDRESS: STREET 1: BIOBRIT, LLC STREET 2: 2223 AVENIDA DE LA PLAYA, SUITE 108 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CASTLE BIOSCIENCES INC CENTRAL INDEX KEY: 0001447362 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770701774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 820 S FRIENDSWOOD DRIVE STREET 2: SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 BUSINESS PHONE: 866-788-9007 MAIL ADDRESS: STREET 1: 820 S FRIENDSWOOD DRIVE STREET 2: SUITE 201 CITY: FRIENDSWOOD STATE: TX ZIP: 77546 4 1 wf-form4_161541047963828.xml FORM 4 X0306 4 2021-03-08 0 0001447362 CASTLE BIOSCIENCES INC CSTL 0001236397 BRADBURY DANIEL C/O CASTLE BIOSCIENCES, INC. 820 S. FRIENDSWOOD DRIVE, SUITE 201 FRIENDSWOOD TX 77546 1 0 0 0 Common Stock 2021-03-08 4 S 0 1700 65.894 D 349293 I By LLC Common Stock 2021-03-08 4 S 0 2795 67.10 D 346498 I By LLC Common Stock 2021-03-08 4 S 0 1805 68.041 D 344693 I By LLC Common Stock 2021-03-08 4 S 0 1200 68.961 D 343493 I By LLC Common Stock 2021-03-09 4 S 0 2675 61.802 D 340818 I By LLC Common Stock 2021-03-09 4 S 0 1914 62860 D 338904 I By LLC Common Stock 2021-03-09 4 S 0 387 64.044 D 338517 I By LLC Common Stock 2021-03-09 4 S 0 995 65.264 D 337522 I By LLC Common Stock 2021-03-09 4 S 0 383 66.022 D 337139 I By LLC Common Stock 2021-03-09 4 S 0 946 67.284 D 336193 I By LLC Common Stock 2021-03-09 4 S 0 200 68.81 D 335993 I By LLC Common Stock 157781 I By Daniel Bradbury Irrecovable Descendant's Trust Common Stock 157804 I By Annette Bradbury Irrecovable Descendant's Trust The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by BioBrit, LLC (the "LLC") on September 5, 2020. This transaction was executed in multiple trades at prices ranging from $65.480 to $66.460, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Held by the LLC, of which the Reporting Person is the managing member and has voting and investment power over the shares. This transaction was executed in multiple trades at prices ranging from $66.495 to $67.445, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $67.620 to $68.450, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $68.730 to $69.380, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $61.270 to $62.260, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $62.420 to $63.300, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $63.570 to $64.550, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $64.710 to $65.690, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $65.720 to $66.680, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $66.900 to $67.750, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Held by Daniel Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. Held by Annette Bradbury Irrecovable Descendant's Trust of which the reporting person and his spouse are trustees and their children are beneficiaries. /s/ Greg Acosta, Attorney-in-fact 2021-03-10